Recent Developments in Gastroenterology Market | DelveInisght
How Robots Are Introducing A New Dimension To Healthcare Service Delivery
Crohns-Disease-Market
Novel Therapies form the Nucleus of t...

Crohn's disease is one of the most prevalent types of Inflammatory bowel diseases characterized by abdomina...

Latest-pharma-biotech-news-updates-for-gsk-pfizer-biontech-biovac-seres-therapeutics
Commencement of AAIC; GSK’s Shingles ...

Alzheimer's Association International Conference (AAIC) 2021 Opens With Thrilling Details of Pharmas and Po...

Benefits-advantage-Disadvantages-pros-and-cons-of-wearable-health-devices-technologies
Wearable Devices: Weighing the Potent...

Wearables are electronic devices that are worn on the body part to track, analyze and transmit real-time pe...

Another Failed NASH Drug; Takeda’s Dengue Shot; Innovent’s Cholangiocarcinoma Clinical Trial; TLX66 in AL Amyloidosis
TLX66 in AL Amyloidosis; Takeda’s Dengue Shot; Innovent’s Cholangiocarcinoma Clinical Trial; Anot...

TLX66 Meets Study Objectives, Holding Out in AL AmyloidosisTelix Pharmaceuticals reported the results from the TRALA trial (Targeted Radiotherapy for AL Amyloidosis), a Phase I/IIa trial evalu...


recent-pharma-biotech-news-updates-for-sanofi-gsk-apellis-innocare-landos
InnoCare’s Trial In China; Sanofi/GSK COVID-19 Vaccine; Apellis’s Empaveli for PNH; LianBio...

InnoCare Receives Go-ahead for Clinical Trial of TYK2 Inhibitor ICP-332 in ChinaInnoCare, a biopharma firm developing novel therapies for the treatment of cancer and autoimmune diseases, today...


recent-biotech-pharma-lifescience-industry-news-updates-for-adagio-lyndra-bms-anixa
Adagio Raises $336 M; Lyndra’s Schizo Trial; BMS Opdivo for Gastric Cancer; Anixa Ovarian C...

Adagio Raises $336 Million to Advance Covid-19 Antibody TreatmentAn antibody startup Adagio Therapeutics announced the completion of a $336 million Series C financing round. The proceedings fr...


Alpha-1-Antitrypsin-Deficiency-Market-Symptoms-Treatments-Key-Companies
Alpha-1 Antitrypsin Deficiency: Symptoms, Treatments and Key Companies in the Market

Alpha1-antitrypsin deficiency (AATD) was first identified by Carl-Bertil Laurell and Sten Eriksson (Laurell and Eriksson 1963) in 1963,  who discovered a link between low plasma serum AAT lev...


robot-robotics-in-healthcare-medical-sector-benefits-disadvantages-and-future-scope-applications-uses
How Robots Are Introducing A New Dimension To Healthcare Service Delivery

Artificial intelligence and robotics are the two technologies that have shown the potential to address and provide solutions to many contemporary issues. The manufacturing sector has been using ro...


recent-pharma-biotech-news-updates-for-verily-janssen-avrobio
Verily – Janssen collaboration; Enhancing the response in pancreatic cancer; Avrobio gene t...

Verily collaborates with Janssen to launch COVID-19 immune response studyVerily is partnering with Johnson & Johnson’s Janssen division to witness the body’s earliest immune responses to a...


Chronic Obstructive Pulmonary Disease Market
Chronic Obstructive Pulmo...

According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....

Myelodysplastic Syndrome (MDS) Market Analysis
Myelodysplastic Syndrome ...

Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....

Prostate Cancer Market
Prostate Cancer...

Prostate Cancer is the second most common malignancy in men worldwide, after lung cancer. Most Prost.....

Editor's Pick
Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the...

Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...

Healthcare Data Breach: What it Means for Companies and the Consumer?

Data and analytics today are playing a major role in the organization’s growth. Stakeho...

Onychomycosis Therapy Market Set to Balloon Up as Emerging Novel Therapies Co...

Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...

Angelman syndrome Pipeline: Unmet needs call for a robust pipeline

The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...

The New Buzz of Transcranial Stimulation Devices in the Neurological Disorder...

Neurological disorders are one of the major causes of death and disability across the g...